Noel Thomas Patton


Noel Patton is the founder and CEO of T.A. Sciences, a consumer health and wellness company dedicated to discovering and creating groundbreaking products through Telomerase Activation (TA). Bringing more than 40 years of experience in business management and manufacturing, Mr. Patton founded the company after becoming personally interested in anti-aging medicine and Telomere Biology.

Mr. Patton’s interest in this area was sparked by a speech from Professor Jerry Shay of the University of Texas Southwest who discussed a naturally occurring enzyme called telomerase that could make human cells "young" again. He immediately contacted, and ultimately invested in, Geron Corporation, the California-based biotech company that was the industry leader in developing this new scientific frontier. His investment enabled Geron to do further research on telomeres and telomerase, which led to the discovery of the cellular rejuvenation properties of the single molecule which is now called TA-65.

In 2002 he secured exclusive worldwide rights to Geron's Telomerase Activation technology for non-prescription nutraceutical and cosmeceutical products. In 2007, after five years of development and safety testing, the first pills containing TA-65 were introduced to the market from T.A. Sciences’ office in New York City. In 2012 the company further acquired exclusive rights for development of TA-65 for FDA-approved drugs. Under his guidance, T.A. Sciences has become the leader in the field of cellular rejuvenation and age management through Telomerase Activation.

Mr. Patton is a frequent guest on TV and radio shows explaining the age-reversing potential of Telomerase Activation (TA) and speaks at various medical and scientific conferences. He travels extensively around the world developing the market for TA-65. T.A. Sciences is rapidly growing; more than 10,000 clients are taking TA-65.


  • Bachelor’s, Indiana University
  • Harvard Business School, Harvard University


  • Member, Buck Advisory Council, The Buck Institute for Research on Aging
Change text size: